- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: hyoscine butyl bromide
Total 955 results
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Boehringer IngelheimCompletedGastrointestinal Diseases
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Netherlands, Norway
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingAlcohol Drinking | Cannabis | Alcohol Use Disorder | Cannabis UseUnited States
-
National Cancer Institute (NCI)CompletedDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Johnson & Johnson Consumer and Personal Products...Completed
-
Seoul National University HospitalCompletedEffect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS) (POTS)Postural Orthostatic Tachycardia SyndromeKorea, Republic of
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Samsung Medical CenterCompletedBrain Tumor | General Anesthesia | Cerebral Aneurysm | Neurosurgery | Spine Tumor | Motor Evoked Potential MonitoringKorea, Republic of
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveSouth Africa
-
Boehringer IngelheimCompleted12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDPulmonary Disease, Chronic ObstructiveGermany, Italy, Switzerland, South Africa
-
Huazhong University of Science and TechnologyUnknown
-
Boehringer IngelheimTerminatedPulmonary Disease, Chronic ObstructiveUnited States, Austria, Canada, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Slovakia, South Africa, Sweden
-
Boehringer IngelheimTerminatedPulmonary Disease, Chronic ObstructiveUnited States, Austria, Belgium, Canada, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Slovakia, Sweden
-
University of AarhusNovo Nordisk A/S; Lundbeck Foundation; Svend Faelding Humanitarian Foundation; Copenhagen... and other collaboratorsTerminatedDiabetes Mellitus | Gastrointestinal Motility Disorder | Change of Transit or Circulation | Diabetic Autonomic NeuropathyDenmark
-
Massachusetts General HospitalWithdrawnMajor Depressive DisorderUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, France, Germany, Russian Federation, Ukraine, Italy, Norway
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveBelgium, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
IRCCS Azienda Ospedaliera Universitaria San Martino...CompletedObliterative BronchiolitisItaly
-
sammour.ramiUnknownPremature Rupture of Membrane | Prelabor Rupture of MembranesIsrael
-
University of DundeeBoehringer Ingelheim; NHS TaysideCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Sunovion Respiratory Development Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Czechia, Hungary, Russian Federation
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDPulmonary Disease, Chronic ObstructiveCanada, United States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveNetherlands
-
University of WashingtonCenters for Disease Control and Prevention; Harborview Injury Prevention and...RecruitingPain, Postoperative | Trauma | Opioid Use | Opioid-use Disorder | Opioid Use, UnspecifiedUnited States
-
Enrique de-MadariaFundación para el Fomento de la Investigación Sanitaria y Biomédica de la... and other collaboratorsUnknown
-
Guangzhou Institute of Respiratory DiseaseRecruiting
-
Healx LimitedWithdrawnFragile X SyndromeUnited States, Australia
-
Novartis PharmaceuticalsCompletedAsthmaGermany, India, Israel, Poland, Argentina, Russian Federation, Greece, Serbia, Turkey, Hungary, Mexico, Peru, Slovakia, Czechia, South Africa, Taiwan, Vietnam, Spain, Colombia, Chile
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Belgium, Poland, Romania, Croatia, Estonia, Netherlands, Slovakia, Latvia, Lithuania, United Kingdom, Argentina, Bulgaria, Serbia, Austria, Hungary, Spain, Greece, Canada, Denmark, Czechia
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Brazil, China, Guatemala, India, Japan, Latvia, Mexico, Peru, Poland, Russian Federation
-
University of Central ArkansasCompletedPelvic Floor Muscle WeaknessUnited States
-
Elizabeth Berry-KravisCompletedFragile X SyndromeUnited States
-
Capital Medical UniversityCompletedMajor Depressive DisorderChina
-
Radboud University Medical CenterCompletedSmoking | Cardiovascular Disease | Chronic Obstructive Pulmonary Disease | BronchodilationNetherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Boehringer IngelheimCompleted
-
SunovionCompletedChronic Obstructive Pulmonary Disease | Emphysema | BronchitisUnited States
-
NovartisCompletedLung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | COPDUnited States, Germany, Spain, Argentina, Italy, Turkey, Canada, India, Sweden, Korea, Republic of, Taiwan, Puerto Rico
-
Meril Life Sciences Pvt. Ltd.Unknown
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Brazil, China, Colombia, Germany, India, Japan, Mexico, Peru, Poland, Romania